Legal & General Group Plc (LON:LGEN – Get Free Report) insider John Kingman bought 726 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were purchased at an average price of GBX 226 ($3.02) per share, for a total transaction of £1,640.76 ($2,194.70).
Legal & General Group Stock Performance
LGEN stock traded down GBX 0.80 ($0.01) during trading hours on Tuesday, hitting GBX 225.50 ($3.02). 14,204,476 shares of the stock were exchanged, compared to its average volume of 17,023,875. Legal & General Group Plc has a 12 month low of GBX 203.10 ($2.72) and a 12 month high of GBX 259 ($3.46). The company has a current ratio of 1.12, a quick ratio of 0.50 and a debt-to-equity ratio of 722.64. The firm has a market capitalization of £13.17 billion, a P/E ratio of 4,510.00, a P/E/G ratio of 2.34 and a beta of 1.31. The company has a 50-day simple moving average of GBX 225.83 and a two-hundred day simple moving average of GBX 236.78.
Legal & General Group Cuts Dividend
The firm also recently announced a dividend, which was paid on Friday, September 27th. Stockholders of record on Thursday, August 22nd were issued a dividend of GBX 6 ($0.08) per share. The ex-dividend date of this dividend was Thursday, August 22nd. This represents a dividend yield of 2.77%. Legal & General Group’s dividend payout ratio is presently 42,000.00%.
Analyst Ratings Changes
Get Our Latest Analysis on Legal & General Group
About Legal & General Group
Legal & General Group Plc provides various insurance products and services in the United Kingdom, the United States, and internationally. It operates in Legal & General Retirement Institutional (LGRI), Legal & General Investment Management (LGIM), Legal & General Capital (LGC), and Retail segments.
Recommended Stories
- Five stocks we like better than Legal & General Group
- How to Effectively Use the MarketBeat Ratings Screener
- Why Lennar Stock Could Be the Best Play in the Housing Market
- When to Sell a Stock for Profit or Loss
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Short Selling: How to Short a Stock
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Legal & General Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Legal & General Group and related companies with MarketBeat.com's FREE daily email newsletter.